Please login to the form below

Not currently logged in
Email:
Password:

regenerative medicine

This page shows the latest regenerative medicine news and features for those working in and with pharma, biotech and healthcare.

FDA expecting boom in cell and gene therapies

FDA expecting boom in cell and gene therapies

It intends to make “maximum use” of expedited regulatory pathways, including the regenerative medicine advanced therapy (RMAT) designation and accelerated approval, particularly for products that offer potential cures for diseases with

Latest news

More from news
Approximately 2 fully matching, plus 45 partially matching documents found.

Latest Intelligence

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    The next company to play its hand in this biotech-led transformation of medicine will be Bluebird Bio. ... The sickle cell programme has also been named on the FDA’s Regenerative Medicine Advanced Therapy designation (RMAT), a new fast-track

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    Now moving into its next phase of implementation, the vision is to make a genomics medicine service a reality in the UK – which will be a first anywhere in the world. ... An exceptional scientist-entrepreneur, Hackett trained initially in regenerative

  • Health on instalment Health on instalment

    Express Scripts stands ready to do its part.”. Or as the Alliance for Regenerative Medicine’s co founder Michael Werner put it: “When you’ve got products that demonstrate the kind

  • Cell and gene therapies: on course for commercial success? Cell and gene therapies: on course for commercial success?

    Commenters, including the Regenerative Medicine Experts Group in the UK, have suggested that the current Health Technology Assessment (HTA) methodologies, such as the National Institute for Health and Care Excellence (NICE), ... The NICE appraisal

  • Deal Watch July 2016 Deal Watch July 2016

    a privately held regenerative medicine company. ... Acquisition. 80. BioD/ Derma Sciences. Regenerative medicine productions derived from placental &birth tissues for multiple indications.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Paris biocluster appoints Stéphane Roques as new chief Paris biocluster appoints Stéphane Roques as new chief

    It focuses on five strategic areas: biological diagnostics, diagnostic and interventional imaging, regenerative medicine and biomaterials, digital health and translational medicine.

  • Emotive grows medical writing capacity Emotive grows medical writing capacity

    Prior to this she worked at the Swiss Institute for Regenerative Medicine as its project manager and scientific medical writer.

  • Zelluna appoints Miguel Forte as CEO Zelluna appoints Miguel Forte as CEO

    Forte’s expertise is predominantly in regenerative medicine, cell therapy, medical and regulatory affairs industries and is currently chief commercialisation officer and chair of the commercialisation committee for the International Society

  • Avita Medical appoints CEO Avita Medical appoints CEO

    Perry has been a non-executive director for the Cambridge, UK-based regenerative medicine firm since February 2013 and previously served at Novartis in roles such as senior vice president and

  • Eduardo Bravo becomes head of EBE Eduardo Bravo becomes head of EBE

    Bravo has over 25 years of experience in the biopharmaceutical industry, and is a member of the executive committee of the Alliance for Regenerative Medicine (ARM).

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics